The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
350 jobs Number of planned job creations
Announcement Date
13 February 2018
Employment effect (start)
13 February 2018
Foreseen end date
31 December 2021
Description
Medical product manufacturer MSD is to create 350 new jobs in Dublin.
The new positions are in quality, engineering, manufacturing and biochemistry. The products that will be manufactured at the Dublin plant will be biological medicines, particularly in the area of immuno-oncology.
MSD currently employs 1700 across Ireland, having increased its workforce in Ireland by 330 last year.
Sources
13 February 2018: RTE
13 February 2018: Silicon Republic.com
Citation
Eurofound (2018), MSD, Business expansion in Ireland, factsheet number 93254, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/93254.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
